The effect of induction pegylated interferon alfa 2b and ribavirin on early virologic response in genotype 1 chronic hepatitis C

被引:0
|
作者
Lawitz, EJ
Harrison, SA
Cantu, NS
Davis, M
Perkel, M
Vemuru, R
Nguyen, T
Kadakia, S
Ganeshappa, KP
Diamond, K
Matossian, H
Box, TD
Ghandour, E
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A723 / A723
页数:1
相关论文
共 50 条
  • [21] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Irit Rosen
    Michal Kori
    Orly Eshach Adiv
    Baruch Yerushalmi
    Nataly Zion
    Ron Shaoul
    World Journal of Gastroenterology, 2013, (07) : 1098 - 1103
  • [22] VIROLOGICAL RESPONSE TO TREATMENT WITH PEGYLATED INTERFERON ALFA-2B AND RIBAVIRIN CHRONIC HEPATITIS C IN CHILDREN
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    Jendryczka, Ewa
    HEPATOLOGY, 2008, 48 (04) : 855A - 856A
  • [23] Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin
    Bonardi, Renato
    Tabone, Marco
    Manca, Aldo
    Pellicano, Rinaldo
    Ciancio, Alessia
    Rizzetto, Mario
    BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (04) : 303 - 306
  • [24] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Rosen, Irit
    Kori, Michal
    Adiv, Orly Eshach
    Yerushalmi, Baruch
    Zion, Nataly
    Shaoul, Ron
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (07) : 1098 - 1103
  • [25] Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2
    Kanda, Tatsuo
    Imazeki, Fumio
    Azemoto, Ryosaku
    Yonemitsu, Yutaka
    Mikami, Shigeru
    Kita, Kazuhiko
    Takashi, Motohide
    Sunaga, Masahiko
    Wu, Shuang
    Nakamoto, Shingo
    Tawada, Akinobu
    Arai, Makoto
    Kato, Keizo
    Yoshida, Yu
    Koma, Yoshihiro
    Fujiwara, Keiichi
    Fukai, Kenichi
    Suzuki, Noriaki
    Yokosuka, Osamu
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (11) : 3335 - 3342
  • [26] Pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a or alfa-2b with ribavirin in treatment naive patients with genotype 1 chronic hepatitis C
    Di Bisceglie, AM
    Rustgi, VK
    Thuluvath, P
    Davis, M
    Ghalib, R
    Lyons, MF
    Ondovik, MS
    Lopez-Talavera, JC
    HEPATOLOGY, 2004, 40 (04) : 734A - 734A
  • [27] Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2
    Tatsuo Kanda
    Fumio Imazeki
    Ryosaku Azemoto
    Yutaka Yonemitsu
    Shigeru Mikami
    Kazuhiko Kita
    Motohide Takashi
    Masahiko Sunaga
    Shuang Wu
    Shingo Nakamoto
    Akinobu Tawada
    Makoto Arai
    Keizo Kato
    Yu Yoshida
    Yoshihiro Koma
    Keiichi Fujiwara
    Kenichi Fukai
    Noriaki Suzuki
    Osamu Yokosuka
    Digestive Diseases and Sciences, 2011, 56 : 3335 - 3342
  • [28] Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    Kainuma, Mosaburo
    Furusyo, Norihiro
    Kajiwara, Eiji
    Takahashi, Kazuhiro
    Nomura, Hideyuki
    Tanabe, Yuichi
    Satoh, Takeaki
    Maruyama, Toshihiro
    Nakamuta, Makoto
    Kotoh, Kazuhiro
    Azuma, Koichi
    Shimono, Junya
    Shimoda, Shinji
    Hayashi, Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (35) : 4400 - 4409
  • [29] Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b
    Mach, Tomasz H.
    Ciesla, Andrzej
    Warunek, Wioleta
    Janas-Skulina, Urszula
    Cibor, Dorota
    Owczarek, Danuta
    Ciecko-Michalska, Irena
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (12): : 434 - 439
  • [30] Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    Mosaburo Kainuma
    Norihiro Furusyo
    Eiji Kajiwara
    Kazuhiro Takahashi
    Hideyuki Nomura
    Yuichi Tanabe
    Takeaki Satoh
    Toshihiro Maruyama
    Makoto Nakamuta
    Kazuhiro Kotoh
    Koichi Azuma
    Junya Shimono
    Shinji Shimoda
    Jun Hayashi
    World Journal of Gastroenterology, 2010, 16 (35) : 4400 - 4409